Related Experiment Video

Updated: Jun 29, 2026

Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia
05:24

Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia

Published on: February 21, 2021

NKG2D ligands in tumor immunity

N Nausch1, A Cerwenka

  • 1Division of Innate Immunity, German Cancer Research Center, Im Neuenheimer Feld 280, Heidelberg, Germany.

Oncogene
|October 7, 2008
PubMed

Insights

The NKG2D receptor and its ligands are crucial for anti-tumor immunity. Their expression is tightly regulated, with signaling linked to IL-15, impacting immune responses in different cellular contexts.

Area of Science:

  • Immunology
  • Cancer Biology
  • Molecular Biology

Background:

  • The activating receptor NKG2D (natural-killer group 2, member D) is vital for immune responses against tumors.
  • NKG2D ligands are expressed on tumor cells but not healthy tissues, requiring tight regulation.
  • Tumor immune escape can be mediated by modulating NKG2D ligand expression.

Purpose of the Study:

  • To review current knowledge on the NKG2D receptor and its ligands in tumor immunology.
  • To discuss strategies for enhancing NKG2D-mediated anti-tumor responses.
  • To explore mechanisms counteracting tumor immune escape via NKG2D.

Main Methods:

  • Literature review of studies on NKG2D, its ligands, and tumor immunology.
  • Analysis of regulatory mechanisms controlling NKG2D expression and signaling.
  • Synthesis of information on therapeutic strategies targeting NKG2D pathways.

Main Results:

  • NKG2D plays a key role in NK, gammadelta T, and CD8 T cell responses to tumors.
  • NKG2D signaling is coupled to the IL-15 receptor pathway in a cell-specific manner.
  • Regulation of NKG2D ligands is critical for balancing anti-tumor immunity and self-tissue protection.

Conclusions:

  • NKG2D-mediated immunity is a significant factor in tumor surveillance.
  • Understanding the interplay between NKG2D, IL-15, and the tumor microenvironment is crucial for effective cancer immunotherapy.
  • Targeting NKG2D pathways offers potential for novel anti-cancer strategies.

More Related Videos

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...